SGA offers an ML-enabled customized, white-labeled market research solution with proprietary first right to data for you and your team.
Clients often purchase generic, off-the-shelf market reports that enfold everything, where the same insight is shared multiple times. There is nothing proprietary about this data or intelligence that a buyer can claim as their own. However, these reports are seen as a step toward obtaining ad-hoc research and extracting more money from the same client. Unfortunately, this is not custom research.
SGA provides white-labeled market research, where the client is the first owner of the data and the analysis for 24 months. We are a HIPAA-compliant team of multilingual healthcare experts. Our customized market research service is based on a high number of primary interviews across markets. The impaneled team of KOLs (key opinion leaders) at SGA drive different therapeutic areas. Based on the project scope, our analysts connect with our in-house KOLs and obtain their perspective of the specific segment or market, simultaneously using ML tools to compile the most relevant data to corroborate the findings.
SGA's health data and management solutions deliver intelligence alerts, customized research papers, and white papers, enabling our industry partners to stay ahead of the competition, regulatory changes, and pricing wars. The USP lies in the presentation of such data. Based on the client’s preferences, most data sets are presented as interactive, customizable, and accurate dashboards. Clients can plug and play various scenarios to witness the near-term and long-term impact and outcome.
Our white papers are a shorter version of customized market research and are used to design campaigns and visibility in the market. SGA has played a critical role in the pandemic, where our vaccine alerts had assisted a major pharmaceutical company in staying ahead of its competition.
Why SGA
Industry Leader
SGA thrives by its brand promise Life is Possible, and is recognized as the most trusted healthcare market research company.
12+ Languages
Our language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts (US/UK).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
White Papers
The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
White Papers
What Happens When You Invest in Healthcare Consulting and Analytics?
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
